-
Mashup Score: 3Open Comment of Guidelines - 16 hour(s) ago
Open comment allows for key stakeholders to critically review and identify any errors or gaps in a draft guideline prior to its finalization and publication.
Source: society.asco.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 13Telehealth - 3 day(s) ago
Urge your lawmakers to make telehealth flexibilities permanent!
Source: asco.quorum.usCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 7ASCO Statement on FDA Issuing Final Rule Regulating IVDs - 4 day(s) ago
The Food and Drug Administration (FDA) released a final rule April 29 that regulates laboratory-developed tests the same as other in vitro diagnostic tests. This was a response to concerns about the
Source: society.asco.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 64Program Guide – ASCO Meeting Program Guide - 5 day(s) ago
1 – 20 out of 5893 Results for “2024 ASCO Annual Meeting” 5893 Results Select All Presenter: Jens Hoeppner, FAChirg, FACS, MD Presenter: Christian U. Blank, MD, PhD Presenter: Suresh S. Ramalingam MD, FASCO, FACP Presenter: David undefined Spigel, FASCO, MD Presenter: Antonio Giordano MD, PhD Presenter: Sonia Pernas MD, PhD Presenter: Toshinari Yamashita, MD, PhD Presenter: Eva Maria Ciruelos MD, PhD Presenter: Fabrice Andre MD, PhD Presenter: Kevin Kalinsky MD, MS Presenter: Erin Frances Cobain, MD
Source: meetings.asco.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 24
The American Society of Clinical Oncology (ASCO) announced four additional medical schools have been selected to participate in the Society’s Oncology Summer Internship (OSI) Program.
Source: society.asco.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 7Exploring Current Immunotherapy Treatment Approaches in Resectable Non–Small Cell Lung Cancer - 8 day(s) ago
With improved survival benefits with ICIs and targeted therapies in metastatic NSCLC, the use of these agents has made its way into early-stage NSCLC.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet-
Improved survival benefits w/ ICIs & targeted therapies in metastatic #NSCLC have led to these agents being used in early-stage NSCLC. @OncBrothers, @ASridharMD, @ArpanAshokPatel & @IvyLorena_Md explore the current treatment landscape: https://t.co/9F5mB8KHSV #LCSM #ASCODailyNews https://t.co/HyimCZQ4vI
-
-
Mashup Score: 18To Provide Quality Cancer Care, Clinicians Must Appreciate the People Living With the Disease - 9 day(s) ago
An Education Session during ASCO24 will help oncologists foster deeper understanding of the needs of patients and caregivers, especially those from historically marginalized communities.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 0New Collaborative Guideline Highlights the Importance of Multidisciplinary Care for Patients With Osteoradionecrosis - 10 day(s) ago
A joint International Society of Oral Oncology-Multinational Association for Supportive Care in Cancer and ASCO guideline seeks to fill a gap in the clinical guidance for patients with head and neck cancers who develop osteoradionecrosis following their head and neck radiation.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 11Head and Neck Cancer - 10 day(s) ago
Head and Neck Cancer
Source: society.asco.orgCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 12Glecirasib Demonstrates Encouraging Efficacy and Safety in KRASG12C-Mutated NSCLC in Phase 2 Trial From China - 11 day(s) ago
Data from a single-arm phase 2 trial conducted in China showed that glecirasib produced a response rate of 48% in patients with advanced KRASG12C-mutated NSCLC when used in the second- or later-line setting.
Source: dailynews.ascopubs.orgCategories: General Medicine News, Partners & KOLsTweet
We’re accepting comments on our draft guideline protocol treatment of #multiplemyeloma. Submit your feedback by May 24. ➡️ https://t.co/2MPb5L5xV6 #mmsm https://t.co/WjNfEF8Tev